(Q43967738)

28 November 2017

title

Cell surface accumulation of a truncated transmembrane prion protein in Gerstmann-Straussler-Scheinker disease P102L. (English)

1 reference

28 November 2017

0 references

transmembrane protein

0 references

author name string

Ravi Shankar Mishra

1

1 reference

28 November 2017

Yaping Gu

2

1 reference

28 November 2017

Sharmila Bose

3

1 reference

28 November 2017

Susamma Verghese

4

1 reference

28 November 2017

Sudheera Kalepu

5

1 reference

28 November 2017

Neena Singh

6

1 reference

28 November 2017

language of work or name

English

0 references

publication date

19 April 2002

1 reference

Journal of Biological Chemistry

28 November 2017

published in

1 reference

28 November 2017

volume

277

1 reference

28 November 2017

issue

27

1 reference

28 November 2017

page(s)

24554-24561

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200213200

28 November 2017

1 reference

Prion diseases of humans and animals: their causes and molecular basis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200213200

Linkage of a prion protein missense variant to Gerstmann-Sträussler syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200213200

Phenotypic variability of Gerstmann-Sträussler-Scheinker disease is associated with prion protein heterogeneity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200213200

Different patterns of truncated prion protein fragments correlate with distinct phenotypes in P102L Gerstmann-Sträussler-Scheinker disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200213200

Mutant prion proteins in Gerstmann-Sträussler-Scheinker disease with neurofibrillary tangles

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200213200

Serial transmission in rodents of neurodegeneration from transgenic mice expressing mutant prion protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200213200

Interactions between wild-type and mutant prion proteins modulate neurodegeneration in transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200213200

A single amino acid alteration (101L) introduced into murine PrP dramatically alters incubation time of transmissible spongiform encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200213200

Changing a single amino acid in the N-terminus of murine PrP alters TSE incubation time across three species barriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200213200

Truncated forms of the human prion protein in normal brain and in prion diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200213200

A transmembrane form of the prion protein contains an uncleaved signal peptide and is retained in the endoplasmic Reticulum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200213200

A transmembrane form of the prion protein in neurodegenerative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200213200

Transmissible and genetic prion diseases share a common pathway of neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200213200

Most pathogenic mutations do not alter the membrane topology of the prion protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200213200

Proteasomes and ubiquitin are involved in the turnover of the wild-type prion protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200213200

Prion diseases: what is the neurotoxic molecule?

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200213200

Prion protein (PrP) synthetic peptides induce cellular PrP to acquire properties of the scrapie isoform

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200213200

Prion protein peptides induce alpha-helix to beta-sheet conformational transitions

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200213200

Molecular genetics of transmissible spongiform encephalopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200213200

Polymorphism at codon 129 or codon 219 of PRNP and clinical heterogeneity in a previously unreported family with Gerstmann-Sträussler-Scheinker disease (PrP-P102L mutation)

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200213200

Prion peptide 106-126 modulates the aggregation of cellular prion protein and induces the synthesis of potentially neurotoxic transmembrane PrP

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200213200

Prion Protein Aggregation Reverted by Low Temperature in Transfected Cells Carrying a Prion Protein Gene Mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200213200

Proteasomal Degradation and N-terminal Protease Resistance of the Codon 145 Mutant Prion Protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200213200

The Chaperone Protein BiP Binds to a Mutant Prion Protein and Mediates Its Degradation by the Proteasome

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200213200

Specific inhibition of in vitro formation of protease-resistant prion protein by synthetic peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M200213200

21 January 2018

Identifiers

DOI

10.1074/JBC.M200213200

1 reference

28 November 2017

1 reference